Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 15.4.2019 | EN | Official Journal of the European Union | C 139/85 |

---

Action brought on 19 February 2019 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)

(Case T-104/19)

(2019/C 139/86)

Language of the case: English

Parties

Applicant: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: G. Paricheva, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Allergan Holdings France SAS (Courbevoie, France)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark JUVÉDERM — European Union trade mark No 5 807 169

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 19 December 2018 in Case R 2630/2017-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO and the other party to the proceedings before the Board of Appeal to bear their own costs and pay those of the applicant for annulment at every stage of the action for revocation and appeal proceedings, including the cost of these proceedings. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 18 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)